2-219421364-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_001927.4(DES):c.1048C>T(p.Arg350Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R350P) has been classified as Pathogenic.
Frequency
Consequence
NM_001927.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DES | NM_001927.4 | c.1048C>T | p.Arg350Trp | missense_variant | 6/9 | ENST00000373960.4 | NP_001918.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DES | ENST00000373960.4 | c.1048C>T | p.Arg350Trp | missense_variant | 6/9 | 1 | NM_001927.4 | ENSP00000363071.3 | ||
DES | ENST00000477226.6 | n.522C>T | non_coding_transcript_exon_variant | 5/8 | 4 | |||||
DES | ENST00000492726.1 | n.443C>T | non_coding_transcript_exon_variant | 5/6 | 4 | |||||
DES | ENST00000683013.1 | n.436C>T | non_coding_transcript_exon_variant | 4/7 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251398Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135878
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461856Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727226
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74296
ClinVar
Submissions by phenotype
not provided Uncertain:2Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 04, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 13, 2022 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies suggest that desmin protein harboring p.(R350W) results in disruption of desmin filament assembly (Taylor et al., 2007); This variant is associated with the following publications: (PMID: 17439987, 27896284, 29247119, 23299917, 17325244, 20474083, 20448486, 15800015, 22337857, 29926427, 31514951, 28416588, 33500567, 31983221, 32150461, 29386531) - |
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Dilated cardiomyopathy 1I Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Oct 10, 2024 | Based on the classification scheme VCGS_Germline_v1.3.5, this variant is classified as Likely pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with dilated cardiomyopathy 1I (MIM#604765), myofibrillar myopathy 1 (MIM#601419) and Kaeser type neurogenic scapuloperoneal syndrome (MIM#181400) (PMIDs: 29926427, 33373648). (I) 0108 - This gene is associated with both recessive and dominant disease. The majority of disease-associated DES variants exhibit autosomal dominant inheritance, with rare cases of biallelic truncating and missense variants reported for myopathy (PMID: 29926427). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 (v4: 29 heterozygotes, 0 homozygotes). (SP) 0309 - Multiple alternative amino acid changes at the same position have been observed in gnomAD (v4) (highest allele count: 65 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated filament domain (DECIPHER). (I) 0708 - Other missense variants comparable to the one identified in this case have conflicting previous evidence for pathogenicity. Multiple alternative changes, p.(Arg350Pro), p.(Arg350Gln) and p.(Arg350Leu), have been reported. p.(Arg350Pro) has been classified as pathogenic by multiple clinical laboratories, and p.(Arg350Gln) and p.(Arg350Leu) have been classified as VUS by clinical laboratories (ClinVar). (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. This variant has been classified as VUS, likely pathogenic and pathogenic by clinical laboratories in ClinVar. It has also been reported as pathogenic and as VUS in multiple individuals within the literature from cohorts with dilated cardiomyopathy or sudden unexplained death (PMIDs: 17325244, 29247119, 28416588, 29386531, 31983221). (I) 1002 - This variant has moderate functional evidence supporting abnormal protein function. In vitro studies showed severe disruption of the normal desmin filament assembly with clumping and aggregation of cytoplasmic protein (PMID: 17325244). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 13, 2007 | - - |
Primary dilated cardiomyopathy Pathogenic:2
Likely pathogenic, no assertion criteria provided | clinical testing | Blueprint Genetics | Sep 29, 2014 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Feb 05, 2024 | This sequence change in DES is predicted to replace arginine with tryptophan at codon 350, p.(Arg350Trp). The arginine residue is highly conserved (100 vertebrates, UCSC), and is located in the intermediate filament (IF) rod domain. There is a large physicochemical difference between arginine and tryptophan. The highest population minor allele frequency in the population database gnomAD v4.0 is 0.002% (25/1,180,008 alleles) in the European (non-Finnish) population, which is consistent with dilated cardiomyopathy. This variant has been reported in at least seven unrelated individuals with dilated cardiomyopathy (PMID: 17325244, 28416588, 29386531, 31983221, 33823640; ClinVar: SCV000206887.1, SCV001203482.4). An in vitro functional assay with limited validation in neonatal rat myocytes showed that the formation of desmin filaments was affected in the presence of the variant indicating that it impacts protein function (PMID: 17325244). Computational evidence predicts a deleterious effect for the missense substitution (REVEL =0.853). Another missense variant c.1049G>C, p.(Arg350Pro) in the same codon has been classified as pathogenic for DES-related myofibrillar myopathy (ClinVar ID: 16835; PMID: 25394388, 15800015). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as LIKELY PATHOGENIC. Following criteria are met: PM2_Supporting, PM5, PP3, PS3_Supporting, PS4_Moderate - |
Desmin-related myofibrillar myopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 350 of the DES protein (p.Arg350Trp). This variant is present in population databases (rs62636492, gnomAD 0.007%). This missense change has been observed in individuals with dilated cardiomyopathy (PMID: 17325244, 29247119, 29386531; Invitae). ClinVar contains an entry for this variant (Variation ID: 44244). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DES protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects DES function (PMID: 17325244). This variant disrupts the p.Arg350 amino acid residue in DES. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15800015, 17439987, 20448486, 25394388, 27393313). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 05, 2012 | Variant classified as Uncertain Significance - Favor Pathogenic. The Arg350Trp i n DES gene has been reported in 1 55 year old individual with DCM (Taylor 2007). This variant has also been identified in 1/8600 European American chromosomes f rom a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.wash ington.edu/EVS; dbSNP rs62636492). This could represent a presymptomatic individ ual and the overall low population frequency supports pathogenicity. In vitro st udies showed disruption of the desmin filament assembly, although in vitro assay s do not always accurately reflect biological function (Taylor 2007). Arginine ( Arg) at position 350 is highly conserved evolution and computational analyses (b iochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) suggest that t his variant may impact the protein (the accuracy of these tools is unknown). Fin ally, another variant at this position (Arg350Pro) has been reported as a pathog enic variant in individuals with conduction system disease, and cardiac and skel etal myopathy (Bar 2005, Walter 2007, Levin 2010). In summary, the available dat a supports that the Arg350Trp variant may be pathogenic, though additional studi es are needed to fully assess its clinical significance. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | May 09, 2023 | - - |
DES-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 24, 2024 | The DES c.1048C>T variant is predicted to result in the amino acid substitution p.Arg350Trp. This variant was reported in individuals with dilated cardiomyopathy, hypertrophic cardiomyopathy, left ventricular noncompaction, or sudden unexplained deaths (Taylor et al. 2007. PubMed ID: 17325244; Table S3, Lin et al. 2017. PubMed ID: 29247119; Online Table 1, Gigli et al. 2019. PubMed ID: 31514951; Table S1, Hoss et al. 2020. PubMed ID: 32150461; Table S2, Mazzarotto et al. 2021. PubMed ID: 33500567). Functional studies suggested that this variant could disrupt the intracytoplasmic localization (Taylor et al. 2007. PubMed ID: 17325244). However, this variant was also documented in the general population (Andreasen et al. 2013. PubMed ID: 23299917; Table S1, Nouhravesh et al. 2016. PubMed ID: 27896284). This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD and has conflicting interpretations of pathogenicity in ClinVar ranging from uncertain significance to pathogenic (http://www.ncbi.nlm.nih.gov/clinvar/variation/44244). A different nucleotide substitution affecting the same amino acid (p.Arg350Pro) has been reported to be causative for DES-associated disorders (Bar et al. 2005. PubMed ID: 15800015; Walter et al. 2007. PubMed ID: 17439987). Although we suspect that the c.1048C>T (p.Arg350Trp) variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2022 | The c.1048C>T (p.R350W) alteration is located in exon 6 (coding exon 6) of the DES gene. This alteration results from a C to T substitution at nucleotide position 1048, causing the arginine (R) at amino acid position 350 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at